Home

Strides Pharma Science Ltd EPS

Image

Strides Pharma Science Ltd

NSE: STAR

EPS

₹ 47.3

Last updated on: Jan 14, 2026

Key Highlights

  • The Earning per Share of Strides Pharma Science Ltd is ₹ 47.3 as of 14 Jan 26 .
  • The earning per share of Strides Pharma Science Ltd changed from ₹ 364.64 to ₹ 13.84 over 6 quarters. This represents a CAGR of -88.71% .

Historical Earning per Share of Strides Pharma Science Ltd

No data available

* All values are in

Company Fundamentals for Strides Pharma Science Ltd

Market Cap

8,661 Cr

EPS

47.3

P/E Ratio (TTM)

19.9

P/B Ratio (TTM)

3.1

Day’s High

956.75

Day’s Low

920.0

DTE

0.7

ROE

14.4

52 Week High

1024.9

52 Week Low

530.7

ROCE

15.0

Market Price of Strides Pharma Science Ltd

1M

1Y

3Y

5Y

Monitoring Strides Pharma Science Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2026939.65
13 Jan 2026927.6
12 Jan 2026929.35
09 Jan 2026943.05
08 Jan 2026967.55
07 Jan 2026976.05
06 Jan 2026984.55
05 Jan 2026950.75
02 Jan 2026901.05
01 Jan 2026913.55

SWOT Analysis Of Strides Pharma Science Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Strides Pharma Science Ltd

Asset Value vs Market Value of Strides Pharma Science Ltd

Market Value

8,661

Asset Value

Value addition

1.5 X

3,415

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Strides Pharma Science Ltd8661
Sun Pharmaceutical Industries Ltd408019
Divis Laboratories Ltd168752
Torrent Pharmaceuticals Ltd135542
Cipla Ltd115883
Lupin Ltd100267

Historical Market Cap of Strides Pharma Science Ltd

No data available

* All values are in crore

Historical Revenue of Strides Pharma Science Ltd

No data available

* All values are in crore

Historical EBITDA of Strides Pharma Science Ltd

No data available

* All values are in crore

Historical Net Profit of Strides Pharma Science Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Strides Pharma Science Ltd News Hub

Strides Alathur successfully concludes USFDA inspection

Strides Alathur, a wholly owned subsidiary of Strides Pharma Science (Strides) has received an Estab

Read more

19 Aug 24

Strides Pharma arm gets EIR from USFDA for Chennai facility

The good manufacturing practices (GMP) inspection was conducted from 1 April to 5 April 2024. The US

Read more

19 Aug 24

Strides Pharma hits 52-week high after dissolution of US unit

Strides Pharma, as a part of Group entites optimization exercises has liquidated its US unit by the

Read more

16 Aug 24

Strides Pharma Science to hold EGM

Strides Pharma Science announced that an Extra Ordinary General Meeting (EGM) of the Company will be

Read more

09 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Strides Pharma Science Ltd

What is the EPS of Strides Pharma Science Ltd stock?

The Earnings Per Share (EPS) of Strides Pharma Science Ltd is 47.3. An EPS is the amount of net income attributed to each share of a common stock.

How is Strides Pharma Science Ltd EPS calculated?

The EPS of Strides Pharma Science Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Strides Pharma Science Ltd report its EPS?

Strides Pharma Science Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Strides Pharma Science Ltd EPS?

Factors that influence the EPS of Strides Pharma Science Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Strides Pharma Science Ltd EPS growth indicate future performance?

Yes, consistent growth in Strides Pharma Science Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions